悦心健康
(002162)
| 流通市值：31.40亿 | | | 总市值：31.41亿 |
| 流通股本：9.26亿 | | | 总股本：9.26亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,278,144,047 | 938,323,852.48 | 567,322,497.67 | 221,065,012.52 |
| 营业收入 | 1,278,144,047 | 938,323,852.48 | 567,322,497.67 | 221,065,012.52 |
| 二、营业总成本 | 1,287,721,593.93 | 927,455,998.31 | 560,850,334.02 | 230,840,986.97 |
| 营业成本 | 991,286,715.48 | 717,973,987.6 | 424,853,634.94 | 167,798,139.49 |
| 税金及附加 | 13,415,563.36 | 9,856,553.78 | 6,030,318.72 | 2,238,056.23 |
| 销售费用 | 173,798,033.39 | 122,535,962.64 | 80,198,883.91 | 36,844,698.77 |
| 管理费用 | 76,880,743.63 | 51,170,313.84 | 32,886,144.76 | 15,687,909.67 |
| 研发费用 | 10,207,286.32 | 7,897,484.64 | 4,278,818.81 | 1,768,801.66 |
| 财务费用 | 22,133,251.75 | 18,021,695.81 | 12,602,532.88 | 6,503,381.15 |
| 其中:利息费用 | 27,041,616.37 | 21,035,601.78 | 14,567,845.56 | 7,525,122.15 |
| 其中:利息收入 | 5,632,150.51 | 3,505,157.03 | -2,289,011.08 | 1,206,279.41 |
| 加:公允价值变动收益 | -728,000 | -657,700 | -657,700 | - |
| 加:投资收益 | 162,347,667.94 | 174,586,483.93 | 174,566,896.51 | 2,208,237.86 |
| 资产处置收益 | -260,317.88 | -260,317.88 | -260,317.88 | -275,412.22 |
| 资产减值损失(新) | -40,864,881.16 | -5,530,389.83 | -5,530,389.83 | - |
| 信用减值损失(新) | -78,832,029.62 | -88,755,371.08 | -900,165.51 | - |
| 其他收益 | 10,057,507.38 | 6,722,020.85 | 4,087,018.48 | 221,605.41 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 42,142,399.73 | 96,972,580.16 | 177,777,505.42 | -7,621,543.4 |
| 加:营业外收入 | 1,656,289.44 | 1,178,007.12 | 1,089,675.69 | 417,208.21 |
| 减:营业外支出 | 4,377,013.3 | 829,206.87 | 481,115.3 | 462,000.59 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 39,421,675.87 | 97,321,380.41 | 178,386,065.81 | -7,666,335.78 |
| 减:所得税费用 | -8,611,542.43 | -10,854,331.79 | 10,325,895.66 | 13,296.46 |
| 六、净利润 | 48,033,218.3 | 108,175,712.2 | 168,060,170.15 | -7,679,632.24 |
| 持续经营净利润 | 62,099,593.19 | 116,507,796.17 | 175,393,365.64 | -6,030,803.94 |
| 终止经营净利润 | -14,066,374.89 | -8,332,083.97 | -7,333,195.49 | -1,648,828.3 |
| 归属于母公司股东的净利润 | 50,063,818.15 | 108,847,069.54 | 168,545,032.01 | -7,672,898.23 |
| 少数股东损益 | -2,030,599.85 | -671,357.34 | -484,861.86 | -6,734.01 |
| (一)基本每股收益 | 0.05 | 0.12 | 0.18 | -0.01 |
| (二)稀释每股收益 | 0.05 | 0.12 | 0.18 | -0.01 |
| 八、其他综合收益 | -9,261.82 | -68,076,837.19 | -68,083,799.9 | 16,866.21 |
| 归属于母公司股东的其他综合收益 | -5,557.09 | -68,067,953.29 | -68,072,130.92 | 10,119.73 |
| 九、综合收益总额 | 48,023,956.48 | 40,098,875.01 | 99,976,370.25 | -7,662,766.03 |
| 归属于母公司股东的综合收益总额 | 50,058,261.06 | 40,779,116.25 | 100,472,901.09 | -7,662,778.5 |
| 归属于少数股东的综合收益总额 | -2,034,304.58 | -680,241.24 | -496,530.84 | 12.47 |
| 公告日期 | 2024-03-30 | 2023-10-28 | 2023-08-19 | 2023-04-27 |
| 审计意见(境内) | 标准无保留意见 | | | |